Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries (original) (raw)

Early Plus Delayed Hirudin Reduces Restenosis in the Atherosclerotic Rabbit More Than Early Administration Alone Potential Implications for Dosing of Antithrombin Agents

Circulation, 1994

View PDFchevron_right

Dissolution of Mural Thrombus by Specific Thrombin Inhibition With r-Hirudin : Comparison With Heparin and Aspirin

Juan Badimon

Circulation, 1998

View PDFchevron_right

A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty

Jaap Deckers

New England Journal …, 1995

View PDFchevron_right

In Vivo Thrombin Generation and Activity During and After Intravenous Infusion of Heparin or Recombinant Hirudin in Patients With Unstable Angina Pectoris

Marcello Galvani

Arteriosclerosis, Thrombosis, and Vascular Biology, 2000

View PDFchevron_right

Can we reduce thrombin generation during coronary thrombolysis or coronary angioplasty?

Cornelis Kluft

Fibrinolysis, 1995

View PDFchevron_right

Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial

Yung-Kuan Chan

European Heart Journal, 2000

View PDFchevron_right

Inhibition of Thrombin Attenuates Stenosis After Arterial Injury in Minipigs

Dana Abendschein

Journal of the American College of Cardiology, 1996

View PDFchevron_right

Maintenance of patency after thrombolysis in stenotic coronary arteries requires combined inhibition of thrombin and platelets

Sheryl Torr-Brown

Journal of the American College of Cardiology, 1993

View PDFchevron_right

Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion

Dana Abendschein

Circulation, 1991

View PDFchevron_right

Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition

John Fallon

Circulation, 1990

View PDFchevron_right

A four-hour infusion of recombinant hirudin results in long-term inhibition of arterial-type thrombosis in baboons

Philip Badenhorst

Blood, 1995

View PDFchevron_right

Relevance of hemostasis on restenosis in clinically stable patients undergoing elective PTCA

Irene Kreis

Thrombosis Research, 2008

View PDFchevron_right

Recombinant hirudin (HBW 023): Biological data of ten patients with severe venous thrombo-embolism

Andrea Camez

American Journal of Hematology, 1995

View PDFchevron_right

Determination of the dosage of recombinant hirudin to inhibit arterial thrombosis in baboons

Philip Badenhorst

Journal of Pharmaceutical Sciences, 2000

View PDFchevron_right

Inhibition of thrombin generation in recalcified plasma

Thomas Stief

Blood Coagulation & Fibrinolysis, 2007

View PDFchevron_right

Adjunctive therapy with low molecular weight heparin with recombinant tissue-type plasminogen activator causes sustained reflow in canine coronary thrombosis

Tom Saldeen, Wilmer Nichols

American Heart Journal, 1992

View PDFchevron_right

The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal models

O. Iqbal

Thrombosis Research, 1993

View PDFchevron_right

Successful Use of Recombinant Hirudin and Its Monitoring by Ecarin Clotting Time in Patients with Heparin-Induced Thrombocytopenia Undergoing Off-Pump Coronary Artery Revascularization

omer salim

Journal of Cardiac Surgery, 2005

View PDFchevron_right

Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty

Ulrich Sigwart

Circulation, 1993

View PDFchevron_right

Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial

Dean Kereiakes

Circulation, 1994

View PDFchevron_right

The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty

Juan Badimon

Journal of the American College of Cardiology, 1991

View PDFchevron_right

Hirulog-Like Peptide Reduces Balloon Catheter Injury Induced Neointima Formation in Rat Carotid Artery without Increase in Bleeding Tendency

Garry Shen

Journal of Vascular Research, 2001

View PDFchevron_right

Monitoring of hirudin therapy with the thrombelastograph®

Evan Pivalizza

Journal of Clinical Anesthesia, 2002

View PDFchevron_right

Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin

Jeffrey Weitz

The American Journal of Cardiology, 1998

View PDFchevron_right

Thrombin Generation, Inhibition and Clinical Outcomes in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy and Heparin: Results From the GUSTO-I Trial fn1fn1This study was supported by Genentech, Inc., South San Francisco, California; Bayer Corporation, New York, New Yor...

Sherryn Roth

Journal of the American College of Cardiology, 1998

View PDFchevron_right

Effect of Non-Heparin Thrombin Antagonists on Thrombin Generation, Platelet Function, and Clot Structure in Whole Blood

Pantep Angchaisuksiri

Cell Biochemistry and Biophysics, 2003

View PDFchevron_right

Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease

Dan Atar

European Journal of Pharmacology, 2000

View PDFchevron_right

Unchecked thrombin is bad news for troubled arteries

Eric Camerer

Journal of Clinical Investigation, 2007

View PDFchevron_right

Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries (original) (raw)

Related papers